Dr. Zunera Tahir, MD

Dr. Tahir practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Tahir's NPI, 1316289648, was assigned on March 25, 2013. Dr. Tahir graduated from Howard University College Of Medicine in 2013. Dr. Tahir holds California license A132167.

Dr. Tahir's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Tahir's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Tahir is also affiliated with Sharp Memorial Hospital. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Tahir to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tahir practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Tahir's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Tahir is board certified in internal medicine by the American Board of Internal Medicine. Dr. Tahir is licensed in California.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, lupus, muscle pain, fibromyalgia, and limb pain, osteoporosis and rheumatoid arthritis among the conditions Dr. Tahir treats.

CMS data shows 745 Medicare services from Dr. Tahir across 6 procedure codes in 2024, for 148 Medicare patients. Medicare paid $30,819 for them. Every service was in an office.

CMS counts 148 Medicare patients who saw Dr. Tahir in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have arthritis, and 58% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tahir's median patient age at 62, with 70% women.

In 2024, Dr. Tahir wrote 1,579 Medicare Part D claims for 260 patients. 85% of them were for generic drugs. CMS names the drug for 1,362 of them, across 25 drugs with 11 or more claims each, at $1,181,210 in total drug cost. In 2023, CMS named 1,318 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Tahir for performance year 2024, reported as part of a group. Dr. Tahir accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tahir as offering telehealth.

Dmand AI links 3 papers to Dr. Tahir, published from 2008 to 2018. 2008 was the busiest year, with 2. Dr. Tahir's most frequent co-authors are Sarah L. Blair, MD, Arthur F. Kavanaugh, MD and Matthew Mark Schultzel, DO.

CMS Open Payments shows 43 general payments to Dr. Tahir from 10 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $487.

Dr. Tahir graduated from Howard University College Of Medicine in 2013.

Dr. Tahir is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.